These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22245961)

  • 1. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.
    Navaneethan U; Venkatesh PG; Mukewar S; Lashner BA; Remzi FH; McCullough AJ; Kiran RP; Shen B; Fung JJ
    Clin Gastroenterol Hepatol; 2012 May; 10(5):540-6. PubMed ID: 22245961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.
    Florin TH; Pandeya N; Radford-Smith GL
    Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
    Wang MH; Mousa OY; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA
    Inflamm Bowel Dis; 2020 Apr; 26(5):774-779. PubMed ID: 31626701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis.
    Lundberg Båve A; Olén O; Söderling J; ; Ludvigsson JF; Bergquist A; Nordenvall C
    United European Gastroenterol J; 2023 Jun; 11(5):471-481. PubMed ID: 37169725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study.
    Rennebaum F; Demmig C; Schmidt HH; Vollenberg R; Tepasse PR; Trebicka J; Gu W; Ullerich H; Kabar I; Cordes F
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does colectomy in UC patients impact on the PSC onset?: A national registry brings new insights.
    Liefferinckx C
    United European Gastroenterol J; 2023 May; 11(4):319-320. PubMed ID: 37118868
    [No Abstract]   [Full Text] [Related]  

  • 7. Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis.
    Praktiknjo M; Zhou T; Krüsken M; Jacob T; Sprinkart AM; Nowak S; Kimmann M; Dold L; Chang J; Jansen C; Strassburg CP; Luetkens J; Weismüller TJ
    Dig Liver Dis; 2023 Nov; 55(11):1543-1547. PubMed ID: 37586906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urgency and Its Association With Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis.
    Sninsky JA; Barnes EL; Zhang X; Long MD
    Am J Gastroenterol; 2022 May; 117(5):769-776. PubMed ID: 35169109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) Consensus Statement.
    Carbone M; Della Penna A; Mazzarelli C; De Martin E; Villard C; Bergquist A; Line PD; Neuberger JM; Al-Shakhshir S; Trivedi PJ; Baumann U; Cristoferi L; Hov J; Fischler B; Hadzic NH; Debray D; D'Antiga L; Selzner N; Belli LS; Nadalin S
    Transpl Int; 2023; 36():11729. PubMed ID: 37841645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent inflammatory bowel disease and primary sclerosing cholangitis: a review of pre- and post-transplant outcomes and treatment options.
    Hatami B; Pasharavesh L; Sharifian A; Zali MR
    Gastroenterol Hepatol Bed Bench; 2023; 16(3):259-269. PubMed ID: 37767322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
    Gui W; Hole MJ; Molinaro A; Edlund K; Jørgensen KK; Su H; Begher-Tibbe B; Gaßler N; Schneider CV; Muthukumarasamy U; Mohs A; Liao L; Jaeger J; Mertens CJ; Bergheim I; Strowig T; Hengstler JG; Hov JR; Marschall HU; Trautwein C; Schneider KM
    Nat Commun; 2023 Jun; 14(1):3304. PubMed ID: 37280200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microbiota and the gut-liver axis in primary sclerosing cholangitis.
    Hov JR; Karlsen TH
    Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):135-154. PubMed ID: 36352157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
    Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
    World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Shah A; Macdonald GA; Morrison M; Holtmann G
    Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Fousekis FS; Theopistos VI; Mitselos IV; Skamnelos A; Kavvadias A; Katsanos KH; Christodoulou DK
    J Clin Med Res; 2019 Feb; 11(2):81-88. PubMed ID: 30700999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
    Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
    World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
    Fousekis FS; Theopistos VI; Katsanos KH; Tsianos EV; Christodoulou DK
    Gastroenterology Res; 2018 Apr; 11(2):83-94. PubMed ID: 29707074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease in liver transplanted patients.
    Filipec Kanizaj T; Mijic M
    World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
    Conway G; Velonias G; Andrews E; Garber JJ; Yajnik V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2017 Mar; 45(6):814-823. PubMed ID: 28105709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation.
    Nannegari V; Roque S; Rubin DT; Quera R
    Gastroenterol Hepatol (N Y); 2014 Oct; 10(10):626-30. PubMed ID: 27540334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.